A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
Clinical trial NCT06836609 · RECRUITING
Trial details
- NCT number
- NCT06836609
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2027-05-15
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.